Improvement in symptom-related disruptions is associated with fewer days of short-acting beta-agonist use in asthma

Significant indirect healthcare costs are related to uncontrolled asthma, including productivity loss. Days with short-acting beta-agonist (SABA) use is associated with symptom-related disruptions at work, home, and school. Digital self-management platforms may support fewer days with SABA medicatio...

Descripción completa

Detalles Bibliográficos
Autores principales: Kaye, Leanne, Vuong, Vy, Barrett, Meredith A., Boers, Elroy, Guilbert, Theresa
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9438376/
https://www.ncbi.nlm.nih.gov/pubmed/36056022
http://dx.doi.org/10.1038/s41533-022-00299-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9438376/
https://www.ncbi.nlm.nih.gov/pubmed/36056022
http://dx.doi.org/10.1038/s41533-022-00299-3

Ejemplares similares